
|Videos|March 1, 2022
Dr. Eric Klein discusses how IsoPSA works for prostate cancer risk assessment
Author(s)Urology Times staff
“IsoPSA is a way of measuring all the different PSA-related proteins in the blood,” says Eric A. Klein, MD.
Advertisement
In this video, Eric A. Klein, MD, provides an overview of the IsoPSA test and how it works. Klein is Emeritus Professor and Chair of the Glickman Urological & Kidney Institute at Cleveland Clinic and Cleveland Clinic Lerner College of Medicine in Cleveland, Ohio.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












